Next, we overexpressed SPRY4‐IT1 in MCF‐7 cells and knocked down SPRY4‐IT1 in MCF‐7 CSCs, which demonstrated that SPRY4‐IT1 promoted the stemness of breast cancer. Here, SPRY4 is linked to breast carcinoma.